April 09 : Lucknow: Chief Minister Yogi Adityanath attended the Sixth Uttar Pradesh Agricultural Science Congress as the ...

Lucknow: Chief Minister Yogi Adityanath attended the Sixth Uttar Pradesh Agricultural Science Congress as the chief guest on ...

Prefer Newsweek on Google to see more of our trusted coverage when you search. In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes ...

Marc Cummings, president and CEO of Life Science Washington, speaking at a one-day forum focused on AI-driven biotech that was held in Seattle in October 2025. (Life Science Washington Photo) Seattle ...

Biotech stocks saw a major rebound in 2025, with key indexes significantly outperforming the S&P 500. Private investment in longevity science doubled in 2024, highlighting growing interest in ...

Molecular glue-focused biotech f5 Therapeutics has failed to stick around for the long haul, shuttering after six years, according to an announcement from the company’s CEO on LinkedIn. “The past few ...

A controversial political appointee at the Food and Drug Administration plans to step down for a second time, and the biotech company at the center of a recent debate that involved him saw its stock ...

Nvidia (NVDA) and Eli Lilly (LLY, down 7% YTD, forward P/E under 30x) in $1B partnership. Eli Lilly deploys AI for drug discovery via Nvidia partnership and LillyPod supercomputer as biotech provides ...

MinIO Co-CEO Garima Kapoor announces a Databricks partnership enabling direct data reads from on-prem infrastructure — eliminating costly cloud replication. She adds MinIO is cash flow positive, ...

This company is the global leader in its specialty area and has successfully expanded into other areas, too. This player aims to generate $13 billion in sales this year. Biotech companies are all ...

There are hundreds of biotechnology companies today that have never commercialized a drug. For many years, the standard approach in the industry has been to advance the science, prove the asset, and ...